Extend Medicare-negotiated drug prices, out-of-pocket limits for prescription drugs, inflation rebates, and $35 copay cap and no deductible on insulin to ACA and employer markets.
Support extending Medicare-negotiated drug prices, prescription drug out-of-pocket limits, inflation rebates, and insulin cost protections to ACA and employer markets.
Occurrences
Evidence
unverified · Source version 87877 · locator unknown
Full Title To expand the drug price negotiation program under title XI of the Social Security Act and repeal certain changes to the program made by Public Law 119–21, to apply prescription drug inflation rebates under the Medicare program to drugs furnished in the commercial market, and to establish out-of-pocket limits on expenditures for prescription drugs under private health insurance.
unverified · Source version 87879 · locator unknown
Bill Version Reported in Senate (RS) Short Title Improving Needed Safeguards for Users of Lifesaving Insulin Now Act of 2026 Full Title To reduce the price of insulin and provide for patient protections with respect to the cost of insulin.
Assessments
No assessments yet.